Kalayjian 1995b.
Trial name or title | A phase II randomized, double‐blind, placebo‐controlled trial to determine the efficacy of prednisolone therapy in HIV‐associated nephropathy (HIVAN). |
Methods | Randomised, double‐blind, placebo‐controlled |
Participants | 18 years and older of both sex |
Interventions | Prednisolone |
Outcomes | Serum creatinine, urinary protein and creatinine clearance |
Starting date | 02/11/1999 |
Contact information | Kalayjian 1995b |
Notes | Study was prematurely closed because of poor accrual |